Amgen's Imdelltra receives US FDA approval to treat adult patients with extensive─stage small cell lung cancer
Amgen announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based …